Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Roth bullish on Cardiol, says trial results enough to attract larger partner
2d ago
CRDL
Premium
Ratings
Optimistic Buy Rating for Cardiol Therapeutics Amid Promising Clinical Trial Results and Strategic Advancements
2d ago
CRDL
Premium
The Fly
Cardiol ARCHER study not statistically significant, says Canaccord
2d ago
CRDL
Premium
The Fly
Cardiol falls 14% to $1.16 after myocarditis study results
2d ago
CRDL
Premium
The Fly
Cardiol data readout positive and not priced in, says H.C. Wainwright
2d ago
CRDL
Premium
The Fly
Cardiol Therapeutics announces Phase II ARCHER results in myocarditis
2d ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Promising Phase II Trial Results for CardiolRx™ in Acute Myocarditis
2d ago
CRDL
Premium
Ratings
Positive Outlook for Cardiol Therapeutics Amid ARCHER Trial Progress and Market Potential
17d ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis
17d ago
6K
CRDL
Premium
Ratings
Buy Rating for Cardiol Therapeutics: Promising Innovations in Heart Disease Treatment with CardiolRx and CRD-38
2M ago
CRDL
Premium
The Fly
Cardiol Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Announces AGM Results and New Board Member
2M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Q1 2025 Financial Results
2M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials
2M ago
6K
CRDL
Premium
Ratings
Promising Clinical Developments and Investment Potential in Cardiol Therapeutics
3M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Q1 2025 Financial Results
3M ago
6K
CRDL
Premium
Ratings
Promising Prospects for Cardiol Therapeutics: Buy Rating Backed by Strong Market Potential and Innovative Treatment Developments
3M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress
3M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025
3M ago
6K
CRDL
Premium
Ratings
Buy Rating for Cardiol Therapeutics Driven by CardiolRx Progress and MAVERIC Phase 3 Trial Initiation
4M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Commences Phase III Trial for CardiolRx™ in Recurrent Pericarditis
4M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Increased Losses Amid Rising Expenses
4M ago
CRDL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
